Related Experiment Video
Updated: May 30, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
205
Patient Perspectives on Personalized Risk Communication Using Polygenic Risk Scores to Inform Colorectal Cancer
Shauna R Goldberg1, Linda K Ko2,3, Li Hsu2
1Kaiser Permanente Colorado Institute for Health Research, Aurora, Colorado.
AJPM Focus
|January 27, 2025
Summary
Younger adults understood their personalized polygenic risk scores for colorectal cancer screening. This approach may help engage this demographic in cancer prevention and informed health decisions.
Area of Science:
- Oncology
- Genetics
- Public Health
Background:
- Colorectal cancer (CRC) incidence is rising in individuals under 50.
- New U.S. guidelines recommend CRC screening start at age 45.
- Polygenic risk scores (PRS) offer personalized risk assessment for CRC.
Purpose of the Study:
- To assess patient understanding of PRS results.
- To evaluate the use of PRS in informing CRC screening decisions.
- To explore patient engagement with personalized genetic risk information.
Main Methods:
- 20 adults aged 46-51 years, offered but not yet screened for CRC, provided saliva for PRS analysis.
- Participants underwent semistructured interviews post-PRS results.
- Thematic analysis was used to interpret qualitative interview data.
Main Results:
- 19 participants completed PRS testing and interviews.
- One participant had high PRS for CRC.
- Interviews revealed participant understanding, trust in PRS, risk perception, and screening intentions.
Conclusions:
- Participants demonstrated understanding and interest in their PRS results.
- Further research is needed to develop guidelines and educational materials for PRS implementation.
- Provider engagement strategies are crucial for integrating PRS into clinical practice.
Related Concept Videos
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
115
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
115
Human Genetics
528
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
528

